Black Rose IndusQ1 FY24

Black Rose Indus Q1 FY24 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹106.74P/E: 15.7Market Cap: ₹544 CrSector: Chemicals & Petrochemicals

Management growth scorecard

Revenue

Category 4

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 4
  • Company expects positive growth in sales and volumes in the current year driven by improved market demand and price realizations.
  • Focus on achieving about 10% profit margins typical for the year.
  • Expansion plans with new capacity additions primarily in the subsequent year.
  • Increased export volumes, especially in manufacturing division, supported by EU and Turkey REACH registrations, boosting exports and revenues.
  • New orders for N-Methylol Acrylamide (NMA) from multinational and domestic customers expected to substantially increase volumes.
  • Commercial launch of Polyacrylamide Solids targeted by Q3 FY25, expected to add to revenue streams.
  • Despite challenges like Chinese dumping affecting domestic sales, exports and better price realizations should drive growth.
  • Emphasis on maximizing revenues and profit over mere capacity utilization for new product lines.
  • Overall good growth expected in both distribution and manufacturing divisions compared to previous periods.

See what Black Rose Indus management said on margin guidance — free account, 30 seconds.

Fundraise plans

  • There is no mention of any current or planned fundraising through debt or equity in the transcript.
  • The company maintains a strong financial position with a negligible Debt Equity Ratio of 0.01.
  • Focus is on optimizing inventory and reducing sundry debtors to support future projects and business prospects.
  • CapEx plans are mainly related to capacity expansion and technology development, but funding sources are not specified as new fundraising.
  • No explicit discussion about raising funds through equity or additional debt during the call.

See what Black Rose Indus management said on order book — free account, 30 seconds.

Capex plans

Yes
- The company is developing new technology for Polyacrylamide Solids with a target commercial launch by Q3 FY25; CapEx estimated between ₹60 to ₹100 crores depending on finalized technology and equipment sourcing. - A specialty chemical manufacturing project in collaboration with a Japanese principal is in advanced discussion; no fresh land purchase needed, site identified at Jhagadia. - Toll manufacturing projects for U.S. and European companies in acrylamide-related products are underway, requiring additional CapEx. - Facility for manufacturing carboxylic acid is already available; only process/technology development is needed, involving no capital investment. - New capacity additions for other products are expected in subsequent years; current year focuses on market demand and price improvements. - CapEx is planned but balanced against margins and market realities; typical target margin of about 10% for the year. Overall, strategic investments focus on expanding manufacturing capabilities in specialty chemicals and related products with moderate CapEx and leveraging existing infrastructure.

Track Black Rose Indus — get its next earnings analysis in your feed

How does Black Rose Indus rank vs peers in Chemicals & Petrochemicals?

Pro feature
ThisBlack Rose Indus
Rev 4Mar 3

How does Black Rose Indus rank in Chemicals & Petrochemicals?

Compare Black Rose Indus against every Chemicals & Petrochemicals company (Q1 FY24) on revenue, margins and earnings-call signals.

View Chemicals & Petrochemicals leaderboard →

Others in Chemicals & Petrochemicals this season

  • Seya Industries (Q2 FY27)

    Revenue from Operations (Net) for the quarter ended September 30, 2026: ₹0 lakhs (no sales reported). Key results statement takeaways from Seya Industries Ltd's

  • DCM Shriram Fine Chemicals (Q2 FY27)

    9,622.39 lakhs for the quarter ended September 30, 2025, indicating a year-on-year decrease of approximately 7.8%. Key results statement takeaways from DCM Shri

  • Dhariwalcorp (Q2 FY27)

    For the half year ended September 30, 2026, consolidated revenue from operations is ₹23,640.36 lakhs, up from ₹17,767.97 lakhs in the previous comparable…

  • Agastya Energy (Q2 FY27)

    For the quarter ended 30th September 2026, the consolidated revenue from operations was ₹625.15 lakhs, down from ₹4410.2 lakhs in the same quarter last year…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →